Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
LUMICKS logo — See more. Know more.

LUMICKS

See more. Know more.

Founded 2014 The Netherlands The Netherlands 123 employees Debt Financing Total: $77.85M Biotechnology, Life Sciences +1

General Information

Company Name LUMICKS
Founded Year 2014
Location The Netherlands The Netherlands
Employees 123
Industries Biotechnology, Life Sciences, Medical Devices
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with LUMICKS. To contact LUMICKS, visit lumicks.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does LUMICKS compare?

A PDF of LUMICKS and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting LUMICKS soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About LUMICKS

LUMICKS is a leading provider of dynamic single-molecule and cell avidity analysis instruments, aiming to empower scientists with tools that reveal crucial insights at the molecular and cellular level. Leveraging innovative and Nobel Prize-winning technologies, such as optical tweezers and STED super-resolution, the company's instruments enable the analysis of complex dynamic details related to the behavior and interaction of single molecules and cells, contributing to a deeper understanding of life at its smallest scale. Founded in 2014, LUMICKS operates within the Biotechnology, Life Sciences, and Medical Devices industries, with its headquarters located in The Netherlands. The company's latest investment, a Debt Financing round, was secured on 10th October 2024. Despite the absence of specific investor details, this investment signifies confidence in LUMICKS' innovative solutions. The company's focus on advancing science and improving human health by providing tools that unlock the measurement of forces and interactions in biology demonstrates its commitment to making meaningful contributions to the field. By directly linking structural and ‘omics analysis to functional outcomes at both a molecular and cellular level, LUMICKS' unparalleled solutions offer the potential to revolutionize research by enabling detailed real-time analysis of underlying biological mechanisms.

Business keywords: Life Sciences, Cell Biology, Molecular Biology, Single-Molecule Analysis, Cell Avidity Analysis, Optical Tweezers, Fluorescence Microscopy, Microfluidics, Acoustic Force Spectroscopy, Cancer Research, Immune Cell Analysis, Biological Mechanisms, Real-time Analysis

Services & Products

dynamic single-molecule analysis
cell avidity analysis
real-time analysis tools

Target Customers

academic researchers pharmaceutical researchers medical research institutions

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing Undisclosed -
10 Oct 2024
Series D €77.60M 8
Pura Vida Investments Gilde Healthcare T. Rowe Price
Pura Vida Investments, Gilde Healthcare +6
16 Apr 2021
Series A Undisclosed 1
Gilde Healthcare
Gilde Healthcare
01 Jan 2017
Grant Undisclosed 1
Horizon 2020
01 May 2015
Grant €250.00K -
14 Jan 2015
Pre Seed Round Undisclosed -
01 Oct 2014

Latest News

View All
EU backs Dutch scaleup Lumicks to fast-track discovery of cancer treatments — Thenextweb
EU backs Dutch scaleup Lumicks to fast-track discovery of cancer treatments
Thenextweb Oct 12, 2024

LUMICKS Alternatives & Competitors

View All Alternatives
LUMICKS vs
Interherence
Interherence Germany

High-sensitivity microscopy for everyone

23 employees
Biotechnology, Life Sciences
Compare LUMICKS vs Interherence
LUMICKS vs
ONI
ONI United Kingdom

See protein, DNA and RNA molecules that make life work, in nanoparticles, viruses, bacteria, cells a...

Series B
210 employees
Biotechnology, Life Sciences
Compare LUMICKS vs ONI
LUMICKS vs
Ademtech
Ademtech France

Superparamagnetic nanoparticles for life sciences and in-vitro diagnostics

Seed
29 employees
Biotechnology, Life Sciences
View all alternatives

FAQ About LUMICKS

See more. Know more.
LUMICKS was founded in 2014.
LUMICKS is headquartered in The Netherlands.
LUMICKS operates in Biotechnology, Life Sciences and Medical Devices. Its work centres on Life Sciences, Cell Biology, Molecular Biology and Single-Molecule Analysis. Its customers include academic researchers, pharmaceutical researchers and medical research institutions.
LUMICKS has approximately 123 employees.
LUMICKS has completed 6 funding rounds, raising a total of $77.85M. The latest funding stage is Debt Financing.
LUMICKS offers: dynamic single-molecule analysis, cell avidity analysis, real-time analysis tools.
Top alternatives and competitors to LUMICKS include Interherence, ONI, Ademtech, IVIM Technology, MNM Bioscience. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
LUMICKS and Interherence are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for LUMICKS, https://bouncewatch.com/company/lumicks, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes